These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6942520)

  • 21. Treatment of 100 cases of chronic myeloid leukemia with Myleran.
    Pawelski S; Topolska P; Rechowicz K; Krzyzanowska-Wozniakowska
    Pol Med Sci Hist Bull; 1968 Jul; 11(3):101-4. PubMed ID: 5243952
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic myeloid leukaemia: course, life expectancy, and an analysis of dibromomannitol and busulfan treatment.
    Gerhartz H
    Haematologica; 1972 Apr; 57(11):775-86. PubMed ID: 4200312
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytochemical evaluation of cytostatic drugs action in chronic granulocytic and lymphatic leukemia.
    Orzechowska-Juzwenko K
    Pol J Pharmacol Pharm; 1980; 32(3):271-80. PubMed ID: 6944693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of the duration of the chronic phase in chronic granulocytic leukaemia to the need for treatment during the first year after diagnosis.
    Wareham NJ; Johnson SA; Goldman JM
    Cancer Chemother Pharmacol; 1982; 8(2):205-10. PubMed ID: 6955071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged survival in chronic granulocytic leukaemia after busulphan induced hypoplasia and karyotype conversion.
    Bennett M; Lewis D; Walker H
    Br J Haematol; 1985 Apr; 59(4):738-40. PubMed ID: 3857075
    [No Abstract]   [Full Text] [Related]  

  • 26. [Adrenal function in chronic myeloid leukemia].
    Podolak-Dawidziak M; Silber-Kasprzak D
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):303-9. PubMed ID: 1069455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blastic crisis of chronic myelogenous leukaemia.
    Koza I; Cerný V; Bohunický L; Hal'ko J; Ujházy V; Petrek C; Krizan Z
    Neoplasma; 1969; 16(4):417-26. PubMed ID: 5259327
    [No Abstract]   [Full Text] [Related]  

  • 28. [Modification of the prognosis of chronic myeloid leukemia through current treatment].
    Donner L; Klener P; Roth Z
    Vnitr Lek; 1976 Feb; 22(2):114-9. PubMed ID: 1062868
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chronic myeloid leukemia with a long survival time].
    de Vries SI
    Ned Tijdschr Geneeskd; 1969 Jul; 113(28):1225-6. PubMed ID: 5255682
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prognostic factors in chronic myeloid leukemia. Apropos of 798 cases].
    Jacquillat C; Chastang C; Bancalari G; Weil M; Bernard J
    Ann Med Interne (Paris); 1975; 126(6-7):515-20. PubMed ID: 1065252
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chronic myeloid leukaemia. Clinical study and analysis of therapeutical results in 55 cases].
    Lamas S; Sanjuán I; Zabala P; Millán I; Cabrera R; Barbolla L; Menéndez J; Fernández MN
    Sangre (Barc); 1982; 27(4A):493-507. PubMed ID: 6961564
    [No Abstract]   [Full Text] [Related]  

  • 32. [Survival of 29 cases of chronic myeloid leukemia treated by myleran].
    Petitclerc C; Barry A
    Union Med Can; 1976 Feb; 105(2):210-6. PubMed ID: 1069396
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chromosome aberrations in busulphan therapy (author's transl)].
    Gebhart E; Schwanitz G; Hartwich G
    Dtsch Med Wochenschr; 1974 Jan; 99(2):52-56. PubMed ID: 4520646
    [No Abstract]   [Full Text] [Related]  

  • 34. BCG immunotherapy in chronic myelocytic leukaemia.
    Kardaszewicz E; Siejeńska L
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):32-5. PubMed ID: 1063221
    [No Abstract]   [Full Text] [Related]  

  • 35. [Observations on the terminal course of chronic myeloid leukemia treated by alkylating agents (busulfan)].
    Giovanelli E
    Minerva Med; 1970 May; 61(37):2038-41. PubMed ID: 4097050
    [No Abstract]   [Full Text] [Related]  

  • 36. Survival in chronic granulocytic leukemia. Splenic irradiation vs busulfan.
    Conrad FG
    Arch Intern Med; 1973 May; 131(5):684-5. PubMed ID: 4512787
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic granulocytic leukaemia: comparison of radiotherapy and busulphan therapy. Report of the Medical Research Council's working party for therapeutic trials in leukaemia.
    Br Med J; 1968 Jan; 1(5586):201-8. PubMed ID: 5235190
    [No Abstract]   [Full Text] [Related]  

  • 38. Remission induction in chronic granulocytic leukaemia using intermittent high-dose busulphan.
    Douglas ID; Wiltshaw E
    Br J Haematol; 1978 Sep; 40(1):59-64. PubMed ID: 280361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dysplastic changes of the cervical epithelium caused by busulfan (myleran) (author's transl)].
    Juch E; Lauterbach A
    Geburtshilfe Frauenheilkd; 1982 Jan; 42(1):43-4. PubMed ID: 6949850
    [No Abstract]   [Full Text] [Related]  

  • 40. Improved therapy for chronic granulocytic leukemia.
    Spiers AS
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):370-82. PubMed ID: 367387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.